Clinical Trial Update: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. [Phase 1]

View source ↗

Summary

Phase I study of Cantrixil in ovarian, fallopian tube, and primary peritoneal cancers has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Cantrixil

Snippet

Sponsor: Kazia Therapeutics Limited | Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19